MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

352.88 +2.34 (+0.67%)
Streaming Delayed Price Updated: 3:39 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Top S&P500 movers in Wednesday's session ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings ↗
Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion slightly missed expectations. 
Via Benzinga
News headline image
Cencora Reports Upbeat Q2 Earnings, Revises Fiscal Year 2025 Guidance: Retail’s Pleased ↗
The company raised its fiscal year 2025 adjusted EPS guidance to $15.70 to $15.95 compared to a previous range of $15.30 to $15.60. 
Via Stocktwits
News headline image
Earnings Scheduled For May 7, 2025 ↗
 
Via Benzinga
News headline image
Cencora’s (NYSE:COR) Q1 Earnings Results: Revenue In Line With Expectations
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above... 
Via StockStory
Topics Economy
News headline image
Cencora Reports Fiscal 2025 Second Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora Earnings: What To Look For From COR
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
Indications Suggest CENCORA INC (NYSE:COR) Could Be on the Verge of a Breakout. ↗
CENCORA INC (NYSE:COR) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill
News headline image
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
3 S&P 500 Stocks with Impressive Fundamentals
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding... 
Via StockStory
Topics Stocks
News headline image
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Top S&P500 movers in Thursday's session ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
These S&P500 stocks are moving in today's session ↗
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. 
Via Chartmill
News headline image
Top 3 S&P 500 Winners in a Losing Market
Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals. 
Via MarketBeat
Topics Earnings Stocks World Trade
News headline image
These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue? ↗
A group of S&P 500 stocks have remained resilient as tariffs and earnings concerns cause the market to drop. Future gains may be limited. 
Via Benzinga
Topics Stocks World Trade
News headline image
Cencora: This ‘Recession-Proof’ Stock Just Set New Highs And Is Flashing ‘Buy’ Signals ↗
Valued at $54.20 billion, Cencora is a healthcare solutions provider formerly known as AmerisourceBergen, and is based in Conshohocken, Pennsylvania. 
Via Talk Markets
Topics Stocks / Equities
News headline image
3 Reasons COR Has Explosive Upside Potential
Since April 2020, the S&P 500 has delivered a total return of 101%. But one standout stock has more than doubled the market - over the past five years, Cencora has surged 231% to $285.36 per share. Its... 
Via StockStory
Topics Stocks Supply Chain
News headline image
Spotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q4
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
EXCLUSIVE: AdvisorShares Portfolio Manager Says Market 'Nervous' In 2025, Encourages Investors To Have 'Long-Term Focus' ↗
An ETF portfolio manager highlights how his fund is beating the broader market and what advice he has for investors in 2025 in an exclusive Benzinga interview. 
Via Benzinga
Topics ETFs
News headline image
Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
3 Market-Beating Stocks to Target This Week
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
News headline image
What Analysts Are Saying About Cencora Stock ↗
 
Via Benzinga
News headline image
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Which S&P500 stocks are moving on Monday? ↗
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Q4 Earnings Highlights: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSE:UNH) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
2 Large-Cap Stocks with Exciting Potential and 1 to Avoid
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story